Larysa Kostyuchenko
Overview
Explore the profile of Larysa Kostyuchenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boyarchuk O, Kostyuchenko L, Akopyan H, Bondarenko A, Volokha A, Hilfanova A, et al.
Front Immunol
. 2024 Jul;
15:1428724.
PMID: 39007137
Introduction: Nijmegen breakage syndrome (NBS) is an autosomal recessive disorder, characterized by microcephaly, immunodeficiency, and impaired DNA repair. NBS is most prevalent among Slavic populations, including Ukraine. Our study aimed...
2.
Tar I, Szegedi M, Krasuska-Slawinska E, Heropolitanska-Pliszka E, Bernatowska E, Oncu E, et al.
Cent Eur J Immunol
. 2023 Oct;
48(3):228-236.
PMID: 37901871
Autosomal dominant hyper-IgE syndrome (AD-HIES) is an inborn error of immunity (IEI) caused by a dominant-negative mutation in the signal transducer and activator of transcription 3 (STAT 3). This disease...
3.
Abolhassani H, Avcin T, Bahceciler N, Balashov D, Bata Z, Bataneant M, et al.
Front Immunol
. 2023 Jan;
13:1032358.
PMID: 36605210
Introduction: The J Project (JP) physician education and clinical research collaboration program was started in 2004 and includes by now 32 countries mostly in Eastern and Central Europe (ECE). Until...
4.
Leiding J, Vogel T, Santarlas V, Mhaskar R, Smith M, Carisey A, et al.
J Allergy Clin Immunol
. 2022 Oct;
151(4):1081-1095.
PMID: 36228738
Background: In 2014, germline signal transducer and activator of transcription (STAT) 3 gain-of-function (GOF) mutations were first described to cause a novel multisystem disease of early-onset lymphoproliferation and autoimmunity. Objective:...
5.
Volokha A, Bondarenko A, Chernyshova L, Hilfanova A, Stepanovskiy Y, Boyarchuk O, et al.
Cent Eur J Immunol
. 2021 Nov;
46(2):250-257.
PMID: 34764795
The J Project is a Central-Eastern European collaborative program in the field of physician education and clinical research aimed at improving the clinical care and diagnosis of primary immunodeficiency disorders...
6.
Zielen S, Duecker R, Woelke S, Donath H, Bakhtiar S, Buecker A, et al.
J Clin Immunol
. 2021 Sep;
41(8):1878-1892.
PMID: 34477998
Patients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and...
7.
Boyarchuk O, Makukh H, Kostyuchenko L, Yarema N, Haiboniuk I, Kravets V, et al.
Immunol Res
. 2021 Aug;
69(5):436-444.
PMID: 34427868
The aim of the study was to determine the TREC/KREC levels in the patients diagnosed with ataxia-telangiectasia (AT) and to establish their informative value for early diagnosis of this pathology....
8.
Wolska-Kusnierz B, Pastorczak A, Fendler W, Wakulinska A, Dembowska-Baginska B, Heropolitanska-Pliszka E, et al.
Clin Cancer Res
. 2020 Oct;
27(2):575-584.
PMID: 33082212
Purpose: Nijmegen breakage syndrome (NBS) is a DNA repair disorder with a high predisposition to hematologic malignancies. Experimental Design: We describe the natural history of NBS, including cancer incidence, risk...
9.
Jagle S, Heeg M, Grun S, Rensing-Ehl A, Maccari M, Klemann C, et al.
Clin Immunol
. 2019 Nov;
210:108316.
PMID: 31770611
Germline STAT3 gain-of-function (GOF) mutations have been linked to poly-autoimmunity and lymphoproliferation with variable expressivity and incomplete penetrance. Here we studied the impact of 17 different STAT3 GOF mutations on...
10.
Krivan G, Chernyshova L, Kostyuchenko L, Lange A, Nyul Z, Derfalvi B, et al.
J Clin Immunol
. 2017 Jul;
37(6):539-547.
PMID: 28711959
This multicentre, open-label, prospective, single-arm study was designed to evaluate the efficacy, pharmacokinetics, and safety of IqYmune®, a highly purified 10% polyvalent immunoglobulin preparation for intravenous administration in patients with...